Blog
RSS FeedPosted by Michael Wonder on 13 May 2021
Australia secures Moderna vaccines
13 May 2021 - The Australian Government has secured 25 million doses of the Moderna COVID-19 vaccine to further diversify our ...
Posted by Michael Wonder on 13 May 2021
Provisional determination granted to Pfizer in relation to COVID 19 vaccine (Comirnaty) - for use in individuals 12 years of age and older
13 May 2021 - On 11 May 2021, the Therapeutic Goods Administration granted a provisional determination to Pfizer Australia in ...
Posted by Michael Wonder on 12 May 2021
Moderna announces new supply agreement with Australia for 25 million doses of its COVID-19 vaccine
12 May 2021 - 25 million doses includes 10 million doses of mRNA-1273 to begin delivery in 2021 and 15 ...
Posted by Michael Wonder on 12 May 2021
Pfizer asks UK to clear vaccine for teens
12 May 2021 - Pfizer has submitted data on its COVID-19 vaccine among 12- to 15-year olds to Britain's health ...
Posted by Michael Wonder on 11 May 2021
A shot at vaccine self-reliance via BioCina and University of Adelaide partnership
11 May 2021 - Australia could achieve total COVID-19 vaccine self-reliance within six months and produce enough synthetic vaccine to ...
Posted by Michael Wonder on 11 May 2021
International IP protection at risk for COVID-19 vaccines
11 May 2021 - The global biotech industry is united in its drive for equitable access to COVID-19 vaccines, but ...
Posted by Michael Wonder on 11 May 2021
CMS expanding efforts to grow COVID-19 vaccine confidence and uptake amongst nation’s most vulnerable
11 May 2021 - CMS builds on whole of Government COVID-19 response with vaccination education, offering and reporting. ...
Posted by Michael Wonder on 11 May 2021
Additional measures to allow experts to focus on COVID-19 activities
11 May 2021 - EMA is implementing additional temporary measures to further streamline activities in the European medicines regulatory network ...
Posted by Michael Wonder on 10 May 2021
NSW residents aged in 40-49 age group could get COVID-19 vaccine in coming weeks
10 May 2021 - NSW residents aged 40 to 49 are now eligible to register for a Pfizer vaccination and could ...
Posted by Michael Wonder on 10 May 2021
FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic
10 May 2021 - Today, the U.S. FDA expanded the emergency use authorisation for the Pfizer-BioNTech COVID-19 vaccine for the prevention ...
Posted by Michael Wonder on 10 May 2021
America wants to waive patent protection for vaccines
8 May 2021 - But it will not have an immediate effect on supplies. ...
Posted by Michael Wonder on 10 May 2021
How should the world pay for a Coronavirus disease (COVID-19) vaccine?
10 May 2021 - The potential health and economic value of a vaccine for coronavirus disease (COVID-19) is self-evident given nearly ...
Posted by Michael Wonder on 09 May 2021
US wary of boosting China biotech with COVID vaccine patent waiver
9 May 2021 - The Biden administration is examining ways to ensure that a waiver of COVID-19 vaccine patents to ...
Posted by Michael Wonder on 08 May 2021
AstraZeneca weighs seeking full U.S. approval for COVID-19 shot, skipping emergency use application
7 May 2021 - British drugmaker faces challenges gathering data; may wait to apply for full approval by the FDA, which ...
Posted by Michael Wonder on 07 May 2021
Pfizer and BioNTech initiate rolling submission of biologics license application for U.S. FDA approval of their COVID-19 vaccine
7 May 2021 - - Pfizer and BioNTech today announced the initiation of a biologics license application with the U.S. FDA ...